Metrics From Wearable Devices Can Predict IBD Flares
By Elana Gotkine HealthDay Reporter
FRIDAY, Jan. 24, 2025 -- Physiological metrics from wearable devices can help identify inflammatory bowel disease (IBD) flares, according to a study published online Jan. 16 in Gastroenterology.
Robert P. Hirten, M.D., from the Icahn School of Medicine at Mount Sinai in New York City, and colleagues examined the predictive abilities of physiological metrics, measured using wearable devices in patients with IBD. A total of 309 patients were enrolled across 36 states.
The researchers found significant differences in circadian patterns of heart rate variability between periods of inflammatory flare and remission and between symptomatic flare and remission. During periods of inflammatory flare and symptomatic flare, marginal means for longitudinal heart rate and resting heart rate were higher. During inflammatory flares, lower daily steps were recorded. Heart rate variability, heart rate, and resting heart rate could establish the presence of inflammation among patients with symptoms. Up to seven weeks prior to inflammatory and symptomatic flares, heart rate variability, heart rate, resting heart rate, steps, and oxygenation were significantly altered.
"These findings open the door to leveraging wearable technology for health monitoring and disease management in innovative ways we haven't previously considered," Hirten said in a statement. "Our hope is that, in the future, this approach will significantly enhance the quality of life of our patients."
Several authors disclosed ties to the pharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted January 2025
Read this next
Rebound Weight Gain Common After Discontinuing Antiobesity Medications
FRIDAY, July 25, 2025 -- Antiobesity medications (AOMs) yield weight loss during use, followed by weight regain after discontinuation of treatment, according to a review published...
Patients Face High Out-of-Pocket Costs After Incident Cancer Diagnosis
FRIDAY, July 25, 2025 -- Patients face high out-of-pocket costs (OOPCs) after an incident diagnosis of cancer, with costs increasing with stage of diagnosis, according to a study...
Exposure to PFAS Mixtures Linked to Increased Odds of Type 2 Diabetes
FRIDAY, July 25, 2025 -- In multiethnic populations, exposure to per- and polyfluoroalkyl substance (PFAS) mixtures may be associated with increased odds of type 2 diabetes (T2D)...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.